Having trouble viewing this email? Click Here.

Breaking News
   
Forward I Phase III Trial of Mirvetuximab Sorvtansine in Platinum-resistant Ovarian Cancer Completes Full Enrollment
April 30, 2018
   
Celldex Plans Life After Glembatumumab, Cutting 2 More Drugs From Pipeline
May 11, 2018
   
Understanding Cancer Heterogeneity May Help Avoid Harmful Effects of Chemotherapy
June 7, 2018
   
Recommended Products & Services
 
DrugLnk™ Custom Synthesis   Anti-Antibody ADCs
Advanced synthetic chemistry platform, an extensive library of payloads and linkers.   A series of anti-Antibody ADCs, pre-loaded with toxins.
Technical Support – Case Study
  ADC Case Study-Custom Synthesis of ADC Linker-payload SET The warhead of an antibody-drug conjugate (ADC) is comprised of a cytotoxic payload drug and a molecular linker that covalently bridges the antibody and the payload. Creative Biolabs is dedicated to helping our clients design and prepare highly customized linker and drug-linker complexes for the creation of ADCs using our featured “DrugLnk” services. Download
     
New Technical Document
  A Brief Introduction of Antibody-drug ConjugateCreative Biolabs summarizes a brief introduction of Antibody-drug conjugate, such as structure of ADC, and mechanism of action of ADC. Continue to read
     
Upcoming Meetings & Events in August, 2018
Bispecific Antibody Pipeline Congress
August 20 - 23, 2018. Washington DC, USA
  Immuno-Oncology Summit
August 27 - 31, 2018. Boston, USA
     
Gene Therapy ManufacturingAugust 16 - 17, 2018. Boston, USA   Multidisciplinary and Multimodal Approaches to Drug Delivery: Translation from Principles to PatientsAugust 12 - 17, 2018. West Dover, USA
 
 
 
45-1 Ramsey Road, Shirley, NY 11967, USA
©Copyright 2007-2018 Creative-Biolabs
Tel: 1-631-871-5806    Fax: 1-631-207-8356
info@biolabsantibody.com | www.biolabsantibody.com/adc
If you do not want to receive such messages, send me subject line as "Unsubscribe".